Post Marketing Study to Evaluate the Two Dose Regimens of Nicardipine Injection in Hypertensive Emergency Patients
PHASE4CompletedINTERVENTIONAL
Enrollment
163
Participants
Timeline
Start Date
March 31, 2013
Primary Completion Date
January 31, 2014
Study Completion Date
January 31, 2014
Conditions
Hypertension EmergencyEnd-organ Damage
Interventions
DRUG
Perdipine injection
IV
Trial Locations (5)
100005
Beijing
150086
Harbin
430050
Wuhan
830001
Ürümqi
050000
Shijiazhuang
All Listed Sponsors
lead
Astellas Pharma China, Inc.
INDUSTRY
NCT01872039 - Post Marketing Study to Evaluate the Two Dose Regimens of Nicardipine Injection in Hypertensive Emergency Patients | Biotech Hunter | Biotech Hunter